Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling

Journal of Medicinal Food

Volumn 19, Issue 1, 2016, Pages 1-14

  Zheng, Xi ^a   Lee, Sun Kyeong ^b   Chun, Ock K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

bone loss; bone remodeling; osteoclast; osteoporosis; soy isoflavones

Indexed keywords

DAIDZEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN; PLANT EXTRACT;

BIOAVAILABILITY; BONE REMODELING; DIETARY INTAKE; DRUG BIOAVAILABILITY; EXERCISE; GENETIC DIFFERENCE; HUMAN; INTERVENTION STUDY; MENOPAUSE; MODULATION; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SYSTEMATIC REVIEW (TOPIC); ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; PATHOPHYSIOLOGY; SOYBEAN;

ANIMALS; BONE REMODELING; HUMANS; ISOFLAVONES; OSTEOPOROSIS; PLANT EXTRACTS; SOYBEANS;

EID: 84954133990     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2015.0045     Document Type: Review

References (139)

1. Consensus Development Conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-650.
2. Burge R, Dawson HB, Solomon DH, et al.: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-475.
3. National Osteoporosis Foundation (NOF). America's bone health: The state of osteoporosis and low bone mass in our nation. National Osteoporosis Foundation; Washington, DC: 2002.
4. Wei P, Liu M, Chen Y, et al.: Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med 2012;5:243-248.
5. Cosman F, de Beur SJ, LeBoff MS et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporosis Int. 2014; 25:2359-2381.
6. Nelson HD, Humphrey LL, Nygren P, et al.: Postmenopausal hormone replacement therapy: Scientific review. JAMA2002;288: 872-881.
7. He FJ, Chen JQ: Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms. Food Sci Hum Wellness 2013;2:146-161.
8. Martin TJ, Seeman SE: Bone remodelling: Its local regulation and the emergence of bone fragility. Best Pract Res Clin Endocrinol Metab 2008;22:701-722.
9. Sims NA, Gooi JH: Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008;19:444-451.
10. Parfitt AM: Bone remodeling and bone loss-understanding the pathophysiology of osteoporosis. Clin Obstet Gynecol 1987;30: 789-811.
11. Rodan GA: Introduction to bone biology. Bone 1992;13 suppl: S3-S6.
12. Armas LA, Recker RR: Pathophysiology of osteoporosis new mechanistic insights. Endocrinol Metab Clin 2012;41:475-486.
13. McGarry KA, Kiel DP: Postmenopausal osteoporosis-strategies for preventing bone loss, avoiding fracture. Postgrad Med 2000;108:79-91.
14. Atmaca A, Kleerekoper M, Bayraktar M, et al.: Soy isoflavones in the management of postmenopausal osteoporosis. Menopause 2008;15:748-757.
15. Silverman SL, Madison RE: Decreased incidence of hip fracture in Hispanics, Asians, and blacks: California Hospital discharge data. Am J Public Health 1988;78:1482-1483.
16. Lauderdale DS, Jacoben SJ, Furner SE, et al.: Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol 1997;146:502-509.
17. Tham DM, Gardner CD, Haskell WL: Clinical review 97: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-2235.
18. Kenny AM, Mangano KM, Abourizk RH, et al.: Soy proteins and isoflavones affect bone mineral density in older women: A randomized controlled trial. Am J Clin Nutr 2009;90:234-242.
19. Kuiper GG, Lemmen JG, Carlsson B, et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
20. Yu Z, Li W, Zhang L: Effects of genistein on cell proliferation and differentiation in human osteoblast. Wei Sheng Yan Jiu 2004;33:569-571.
21. Tang XL, Zhu XY, Liu SJ, et al.: Isoflavones suppress cyclic adenosine 30,50-monophosphate regulatory element-mediated transcription in osteoblastic cell line.JNutr Biochem2011;22:865-873.
22. Huang YF, Cao SM, Nagamani M, et al.: Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005;90:3956-3962.
23. Dijsselbloem N, Vanden BW, De NA, et al.: Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multipurpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 2004;68:1171-1185.
24. Kumar N, Allen K, Riccardi D, et al.: Soflavones in breast cancer chemoprevention: Where do we go from here? Front Biosci 2004;1:2927-2934.
25. Song WO, Chun OK, Hwang I, et al.: Soy isoflavones as safe functional ingredients. J Med Food 2007;10:571-580.
26. Ma DF, Qin LQ, Wang PY, et al.: Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: Meta-analysis of randomized controlled trials. Eur J Clin Nutr 2008;62:155-161.
27. Li B, Yu S: Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. BioPharm Bull 2003;26:780-786.
28. Ming LG, Chen KM, Xian CJ: Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol 2013;228:513-521.
29. Sliwinski L, Folwarczna J, Janiec W, et al.: Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro. Pharmacol Rep 2005;57:352-359.
30. Blum SC, Heaton SN, Bowman BM, et al.: Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J Nutr 2003;133:1244-1249.
31. Arjmandi BH, Getlinger MJ, Goyal NV, et al.: Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998;68:1358S-1363S.
32. Mihalache G, Mihalache GD, Indrei LL, et al.: Phytoestrogens role in bone functional structure protection in the ovariectomized rat. Rev Med Chir Soc Med Nat Iasi 2002;106:89-92.
33. Pie JE, Park JH, Park YH, et al.: Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J Nutr Biochem 2006;17:157-164.
34. Gallo D, Zannoni GF, Apollonio P, et al.: Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile. Menopause 2005;12:589-600.
35. Gertz ER, Silverman NE, Wise KS, et al.: Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: A 1-year investigation. J Clin Densitom 2010;13:277-282.
36. SuhKS, KohG, ParkCY, et al.: Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 2003;63:209-215.
37. Arjmandi BH, Khalil DA, Hollis BW: Soy protein: Its effects on intestinal calcium transport, serum vitaminD, and insulin-like growth factor-I in ovariectomized rats. Calcif Tissue Int 2002;70:483-487.
38. Zafar TA, Weaver CM, Jones K, et al.: Inulin effects on bioavailability of soy isoflavones and their calcium absorption enhancing ability. J Agric Food Chem 2004;52:2827-2831.
39. Lien TF, Chen W, Hsu YL, et al.: Influence of soy aglycon isoflavones on bone-related traits and lens protein characteristics of ovariectomized rats and bioactivity performance of osteoprogenitor cells. J Agric Food Chem 2006;54:8027-8032.
40. Paik MK, Lee HO, Chung HS, et al.: Genistein may prevent cadmium-induced bone loss in ovariectomized rats. J Med Food 2003;6:337-343.
41. Legette LL, Martin BR, Shahnazari M, et al.: supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. J Nutr 2009;139:1908-1913.
42. Anderson JJ, Ambrose WW, Garner SC: Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 1998,217:345-350.
43. Dang Z, Lowik CW: The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res 2004,19:853-861.
44. Kim MS, Lee YS: Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats. J Med Food 2005;8:439-445.
45. Kim DW, Yoo KY, Lee YB, et al.: Soy isoflavones mitigate long-term femoral and lumbar vertebral bone loss in middleaged ovariectomized mice. J Med Food 2009;12:536-541.
46. Ye YB, Tang XY, Verbruggen MA, et al.: Soy isoflavones attenuate bone loss in early postmenopausal Chinese women-A single-blind randomized, placebo-controlled trial. Eur J Nutr 2006;45:327-334.
47. Ho SC, Woo J, Lam S, et al.: Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporos Int 2003;14:835-842.
48. Uesugi T, Fukui Y, Yamori Y: Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: A four-week study. J Am Coll Nutr 2002;21:97-102.
49. Picherit C, Coxam V, Bennetau-Pelissero C, et al.: Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000;130:1675-1681.
50. Uesugi T, Toda T, Tsuji K, et al.: Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 2001;24:368-372.
51. Erlandsson MC, Islander U, Moverare S, et al.: Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice. Apmis 2005;113:317-323.
52. Kerstetter JE, Kenny AM, Insogna KL: Dietary protein and skeletal health: A review of recent human research. Curr Opin Lipidol 2011;22:16-20.
53. Scheiber MD, Liu JH, Subbiah MT, et al.: Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 2001;8:384-392.
54. Zhang Y, Li Q, Wan HY, Helferich WG, et al.: Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 2009;139:2230-2236.
55. Devareddy L, Khalil DA, Smith BJ, et al.: Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 2006;38:686-693.
56. Nakai M, Cook L, Pyter LM, et al.: Dietary soy protein and isoflavones have no significant effect on bone and a potentially negative effect on the uterus of sexually mature intact Sprague-Dawley female rats. Menopause 2005;12:291-298.
57. Bahr JM, Nakai M, Rivera A, et al.: Dietary soy protein and isoflavones: Minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause 2005;12:165-173.
58. Potter SM, Baum JA, Teng HY, et al.: Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68:1375S-1379S.
59. Somekawa Y, Chiguchi M, Ishibashi T, et al.: Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001;97:109-115.
60. Kritz-Silverstein D, Goodman-Gruen DL: Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Womens Health Gend Based Med 2002;11:69-78.
61. Chen YM, Ho SC, Lam SSH, et al.: Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: A double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4740-4747.
62. ChenYM, Ho SC, LamSSH,Ho SS, et al.: Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: A double-blind, randomized, controlled trial. Menopause 2004;11:246-254.
63. MoriM, Aizawa T, TokoroM, et al.: Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women. Clin Exp Pharmacol Physiol 2004;31:S39-S41.
64. Newton KM, LaCroix AZ, Levy L, et al.: Soy protein and bone mineral density in older men and women: A randomized trial. Maturitas 2006;55:270-277.
65. Huang HY, Yang HP, Yang HT, et al.: One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect. J Nutr Biochem 2006;17:509-517.
66. Marini H,Minutoli L, Polito F, et al.: Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women-A randomized trial. Ann Intern Med 2007;146:839-847.
67. Alekel DL, Van Loan MD, Koehler KJ, et al.: The Soy Isoflavones for Reducing Bone Loss (SIRBL) study: A 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr 2007;91:218-230.
68. Garcia-Martin A, Charneco MQ, Guisado AA, et al.: Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: Randomized trial. Med Clin (Barc) 2012;138:47-51.
69. Dalais FS, Rice GE, Wahlqvist ML, et al.: Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998;1: 124-129.
70. Hsu CS, Shen WW, Hsueh YM, et al.: Soy isoflavone supplementation in postmenopausal women: Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 2001;46:221-226.
71. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al.: Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women-A randomized controlled trial. JAMA 2004;292:65-74.
72. Roughead ZK, Hunt JR, Johnson LK, et al.: Controlled substitution of soy protein for meat protein: Effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab 2005;90:181-189.
73. Evans EM, Racette SB, Van Pelt RE, et al.: Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women. Menopause 2007;14:481-488.
74. Brink E, Coxam V, Robins S, et al.: Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: A randomized, double-blind, placebo controlled study. Am J Clin Nutr 2008;87:761-770.
75. Dong J HZ, Piao JH, Li F, et al.: Relationship between estrogen receptor gene Px haplotype and the effect of calcium and soy isoflavone supplementation on bone mineral density of Chinese postmenopausal women. Zhonghua Yu Fang Yi Xue Za Zhi 2008;42:329-334.
76. Vupadhyayula PM, Gallagher JC, Templin T, et al.: Effects of soy protein isolate on bone mineral density and physical performance indices in postmenopausal women-A 2-year randomized, double-blind, placebo-controlled trial. Menopause 2009;16:320-328.
77. Wong WW, Lewis RD, Steinberg FM, et al.: Soy isoflavone supplementation and bone mineral density in menopausal women: A 2-y multicenter clinical trial. Am J Clin Nutr 2009;90:1433-1439.
78. Levis S, Strickman-Stein N, Ganjei-Azar P, et al.: Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms a randomized, double-blind trial. Arch Intern Med 2011;171:1363-1369.
79. Tai TY, Tsai KS, Tu ST, et al.: The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: A 2-year randomized double-blind placebocontrolled study. Osteoporos Int 2012;23:1571-1580.
80. Greendale GA, FitzGerald G, Huang MH, et al.: Dietary soy isoflavones and bone mineral density: Results from the study of women's health across the nation. Am J Epidemiol 2002;155: 746-754.
81. Chun OK, Lee SG, Wang Y, et al.: Estimated flavonoid intake of the elderly in the United States and around the world. J Nutr Gerontol 2012;31:190-205.
82. Zhang XL, Shu XO, Li HL, et al.: Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005;165:1890-1895.
83. Anderson JJ CX, Boass A, Symons M, et al.: Soy isoflavones: No effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. J Am Coll Nutr 2002;21:388-393.
84. Chun OK, Chung SJ, Song WO: Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 2009;109:245-254.
85. Ho SC, Chan SG, Yi QL, et al.: Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001;16:1363-1369.
86. Gallagher JC, Satpathy R, Rafferty K, et al.: The effect of soy protein isolate on bone metabolism.Menopause 2004;11:290-298.
87. Tsuang YH, Chen LT, Chiang CJ, et al.: Isoflavones prevent bone loss following ovariectomy in young adult rats. J Orthop Surg Res 2008;3:12.
88. Picherit C, Bennetau-Pelissero C, Chanteranne B, et al.: Soybean isoflavones does-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 2001;131:723-728.
89. Song Y, Paik HY, Joung H: Soybean and soy isoflavone intake indicate a positive change in bone mineral density for 2 years in young Korean women. Nutr Res 2008;28:25-30.
90. Chiechi LM, Secreto G, D'Amore M, et al.: Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: The Menfis randomized trial. Maturitas 2002;42:295-300.
91. Wu J, Oka J, Ezaki J, et al.: Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: A double-blind, randomized, controlled trial. Menopause 2007;4:866-874.
92. Tousen Y, Ezaki J, Fujii Y, et al.: Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: A pilot randomized, placebo-controlled trial. Menopause 2011;18:563-574.
93. Karr SC, Lampe JW, Hutchins AM, et al.: Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 1997;66:46-51.
94. Sehmisch S, Erren M, Kolios L, et al.: Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model. Phytother Res 2010;24:S168-S74.
95. Mathey J, Mardon J, Fokialakis N, et al.: Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: The case for equol. Osteoporos Int 2007;18:671-679.
96. Rachon D, Seidlova-Wuttke D, Vortherms T, et al.: Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas 2007;58:308-315.
97. Kolios L, Sehmisch S, Daub F, et al.: Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats. Planta Med 2009;75:459-465.
98. Atkinson C, Newton KM, Bowles EJ, et al.: Demographic anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among pre-menopausal women in the United States. Am J Clin Nutr 2008;87:679-687.
99. Messina M, Ho S, Alekel DL: Skeletal benefits of soy isoflavones: A review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 2004;7:649-658.
100. Wu J, Wang X, Chiba H, et al.: Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 2004;53:942-948.
101. Shiguemoto GE, Rossi EA, Baldissera V, et al.: Isoflavonesupplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 2007;57:261-270.
102. Florencio-Silva R, Santos MA, de Medeiros VP, et al.: Effects of soy isoflavones and mechanical vibration on rat bone tissue. Climacteric 2013;16:709-717.
103. Chilibeck PD, Vatanparast H, Pierson R, et al.: Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: A randomized clinical trial. J Bone Miner Res 2013;28:780-793.
104. Figard H, Mougin F, Gaume V, et al.: Combined intervention of dietary soybean proteins and swim training: Effects on bone metabolism in ovariectomized rats. J Bone Miner Metab 2006;24: 206-212.
105. Register TC, Jayo MJ, Anthony MS: Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab 2003;88:4362-4370.
106. Mathey J, Puel C, Kati-Coulibaly S, et al.: Fructooligosaccharides maximize bone-sparing effects of soy isoflavoneenriched diet in the ovariectomized rat. Calcif Tissue Int 2004;75:169-179.
107. Fonseca D, Ward WE: Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 2004;35:489-497.
108. Nakai M, Black M, Jeffery EH, et al.: Dietary soy protein and isoflavones: No effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat. Food Chem Toxicol 2005;43:945-949.
109. Breitman PL, Fonseca D, Ward WE: Combination of soy protein and high dietary calcium on bone biomechanics and bone mineral density in ovariectomized rats. Menopause 2005;12:428-435.
110. Watkins BA, Reinwald S, Li Y, et al.: Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats. J Nutr Biochem 2005;16:479-488.
111. Devareddy L, Khalil DA, Korlagunta K, et al.: The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause 2006;13:692-699.
112. Cheng MW, Liu JF, Yi GQ, et al.: Soy isoflavones with supplemental calcium provide protection against the loss of bone mass and influence insulin-like growth factor (IGF)-I after ovariectomy in rat. Zhonghua Yu Fang Yi Xue Za Zhi 2006;40:328-331.
113. Ward WE, Fonseca D: Soy isoflavones and fatty acids: Effects on bone tissue postovariectomy in mice. Mol Nutr Food Res 2007;51:824-831.
114. Om AS, Shim JY: Effect of daidzein, a soy isoflavone, on bone metabolism in Cd-treated ovariectomized rats. Acta Biochim Pol 2007;54:641-646.
115. Sehmisch S, Hammer F, Christoffel J, et al.: Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med 2008;74:794-801.
116. Seidlová-Wuttke D, Jarry H, Jäger Y, et al.: Bone development in female rats maintained with soy-free or soy-containing food as determined by computer-assisted tomography and serum bone markers. J Bone Miner Metab 2008;26:321-327.
117. Jeon BJ, Ahn J, Kwak HS: Effect of isoflavone-enriched milk on bone mass in ovariectomized rats. JMed Food 2009;12:1260-1267.
118. Tezval M, Sehmisch S, Seidlova-Wuttke D, et al.: Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol. Planta Med 2010;76:235-240.
119. Byun JS, Lee SS: Effect of soybeans and sword beans on bone metabolism in a rat model of osteoporosis. Ann Nutr Metab 2010;56:106-112.
120. Hooshmand S, Juma S, Arjmandi BH: Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency. J Med Food 2010;13:320-325.
121. Komrakova M, Sehmisch S, Tezval M, et al.: Impact of 4-methylbenzylidene camphor, daidzein, and estrogen on intact and osteotomized bone in osteopenic rats. J Endocrinol 2011;211: 157-168.
122. Chiang SS, Liao JW, Pan TM: Effect of bioactive compounds in Lactobacilli-fermented soy skim milk on femoral bone microstructure of aging mice. J Sci Food Agric 2012;92:328-335.
123. Nishide Y, Tadaishi M, Kobori M, et al.: Possible role of Sequol on bone loss bia amelioration of inflammatory indices in ovariectomized mice. J Clin Biochem Nutr 2013;53:41-48.
124. Turner RT, Iwaniec UT, Andrade JE, et al.: Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss. Menopause 2013;20:677-686.
125. Srivastava K, Singh AK, Khan K, et al.: Assessment of enhancement of peak bone gain by isoflavone enriched standardized soy extract in female rats. J Funct Foods 2014;7:314-321.
126. Nagata C, Shimizu H, Hayashi M, et al.: Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 2002;13:200-204.
127. Koh WP, Wu AH, Wang RW, et al.: Gender-specific associations between soy and risk of hip fracture in the Singapore Chinese Health Study. Am J Epidemiol 2009;170:901-909.
128. WangenKE, DuncanAM,Merz-Demlow BE, et al.: Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000;85:3043-3048.
129. Harkness LS, Fiedler K, Sehgal AR, et al.: Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health 2004;13:1000-1007.
130. Cheong JMK, Martin BR, Jackson GS, et al.: Soy isoflavones do not affect bone resorption in postmenopausal women: A dose-response study using a novel approach with 41Ca. J Clin Endocrinol Metab 2007;92:577-582.
131. Dalais FS, Ebeling PR, Kotsopoulos D, et al.: The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol 2003;58:704-709.
132. Mori M, Sagara M, Ikeda K, et al.: Soy isoflavones improve bone metabolism in postmenopausal Japanese women. Clin Exp Pharmacol Physiol 2004;31:S44-S46.
133. Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, et al.: Soymilk or progesterone for prevention of bone loss: A 2 year randomized, placebo-controlled trial. Eur J Nutr 2004;43:246-247.
134. Roudsari AH, Tahbaz F, Hossein-Nezhad A, et al.: Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: A before and after clinical trial. Nutr J 2005;4:30.
135. Arjmandi BH, Lucas EA, Khalil DA, et al.: One year soy protein supplementation has positive effects on markers but not bone density in postmenopausal women. Nutr J 2005;4:8.
136. Radhakrishnan G, Agarwal N, Vaid N: Isoflavone rich soy protein supplementation for postmenopausal therapy. Internet J Gynecol Obstet 2008;11:1.
137. Shedd-wise KM, Alekel DL, Hofmann H, et al.: The soy isoflavones for reducing bone loss study: 3-yr effects on pQCT bone mineral density and strength measures in postmenopausal women. J Clin Densitom 2011;14:45-57.
138. Zhou Y, Alekel L, Dixon PM, et al.: The effect of soy food intake on mineral status in premenopausal women. J Womens Health 2011;20:771-780.
139. Yang TS, Wang SY, Yang YC, et al.: Effects of standardized phytoestrogen on Taiwanese menopausal women. Taiwan JObstet Gynecol 2012;51:229-235.